When people start researching NAD+ therapy, they typically encounter two delivery routes: IV infusions administered at a clinic and subcutaneous or intramuscular injections that can be self-administered at home. Both bypass the digestive system. Both achieve meaningfully higher plasma NAD+ levels than oral supplements. The question is whether the difference between them justifies the difference in cost, access, and convenience.
For most people, the answer points clearly toward injections. Here's why.
The Core Issue: Bioavailability and Delivery Method
NAD+ cannot be taken orally with high effectiveness. Digestive enzymes break it down into component parts before it reaches systemic circulation, and the conversion back to active NAD+ in cells is inefficient and variable.
Both IV infusions and injections solve this problem by bypassing the digestive system entirely. This is the core advantage they share over oral supplementation.
The distinction between IV and injection is about peak plasma concentration, rate of delivery, and practical logistics.
How NAD+ IV Drips Work
In an IV infusion, NAD+ is delivered directly into a vein over the course of 1-3 hours. The compound enters the bloodstream immediately and without any absorption lag.
IV infusions achieve the highest peak plasma NAD+ concentrations of any delivery method. The entire dose enters circulation directly and quickly.
Clinical settings typically charge $200-$600 per session for NAD+ IV infusions. Sessions are administered in a clinic or med spa environment, require a nurse or medical professional to place the IV, and take 1-3 hours per session. Most therapeutic protocols recommend 2-5 sessions per week.
Some people experience discomfort during NAD+ IV infusion, including chest tightness, flushing, or nausea, particularly if the infusion rate is too fast. Slowing the drip typically resolves these symptoms.
How NAD+ Injections Work
Subcutaneous (SubQ) injections deliver NAD+ into the fat layer just under the skin, typically in the abdomen or thigh. Intramuscular (IM) injections deliver into muscle tissue. From either site, NAD+ enters the bloodstream through absorption into surrounding capillaries.
Compared to IV, the absorption is slightly slower and peak plasma concentrations are modestly lower. However, the plasma levels achieved with injections are therapeutically meaningful and consistent. For the goals most people pursue with NAD+ therapy, including energy, cognitive support, recovery, and anti-aging, injections produce results that are clinically equivalent to IV infusions for ongoing protocols.
At-home injections take approximately 2 minutes to administer. A licensed provider prescribes the protocol and supplies administration guidance. Medication ships to your door.
Cost is dramatically lower than IV infusions, typically $50-$150 per dose depending on concentration and frequency, compared to $200-$600 for clinic IV sessions.
Direct Comparison: NAD+ Injection vs IV Drip
Peak plasma concentration: IV infusion delivers NAD+ immediately into the bloodstream — very high peak. SubQ/IM injections absorb through tissue and achieve high, therapeutically sufficient levels.
Absorption rate: IV is immediate. Injections reach peak plasma concentration within 15-30 minutes post-administration.
Session duration: IV requires 1-3 hours at a clinic. Injections take approximately 2 minutes at home.
Cost per session: IV typically runs $200-$600. At-home injections are typically $50-$150 per dose.
Monthly cost (3x/week): IV protocols can run $2,400-$7,200 per month. At-home injection protocols typically run $600-$1,800.
Location and administration: IV requires a clinic or med spa with a medical professional. Injections are self-administered at home after brief training from your provider.
Scheduling: IV requires booking clinic appointments during business hours. At-home injections have no scheduling dependency.
Comfort: IV infusions can cause temporary chest tightness, flushing, or nausea if the drip rate is too fast. Injections involve a small gauge needle with minimal discomfort.
The Bioavailability Argument: Does It Actually Matter?
The primary argument for IV over injection is higher peak plasma concentration. IV delivers NAD+ immediately into the bloodstream at the full dose. Injections achieve slightly lower peak levels due to absorption from tissue.
Whether this difference translates into meaningfully better outcomes depends on the specific goal.
For one-time high-intensity loading: If the goal is achieving the highest possible NAD+ concentration in a single session, for example, post-illness recovery or intensive anti-aging loading protocols, IV has an advantage in peak concentration.
For ongoing therapeutic maintenance: For people using NAD+ multiple times per week to maintain elevated plasma levels over months and years, the per-session difference in peak concentration matters much less than consistency and sustainability. A protocol you can maintain 3-4 times per week at home produces cumulative effects that a twice-monthly IV session cannot match, even if each IV session peaks higher.
The research on NAD+'s benefits is largely built on the concept of restoring and maintaining elevated NAD+ levels over time, not achieving single-session spikes. Research from leading institutions supports sustained elevated NAD+ as the relevant therapeutic target.
For sustained protocols, injections win on practical terms.
The Practical Reality of Consistent Treatment
Here is where IV therapy's appeal often breaks down in practice.
Scheduling: Clinic hours, commute time, and the 1-3 hour session commitment make frequent IV infusions impractical for most working adults. A 3x/week IV protocol requires roughly 6-10 hours of clinic time per week, before commuting.
Cost sustainability: At $200-$600 per session, a 3x/week IV protocol costs $2,400-$7,200 per month. This is not sustainable for most people over the months and years that meaningful NAD+ replenishment requires.
Missed doses: Inconvenience leads to missed sessions. Missed sessions reduce the cumulative effect. A theoretically superior treatment that gets used sporadically produces worse real-world outcomes than a more accessible treatment used consistently.
At-home injection protocols eliminate all three of these barriers. A 2-minute injection before your morning routine has a compliance rate that a 2-hour clinic appointment fundamentally cannot match.
This played out clearly for Daniel, a 51-year-old executive. He started NAD+ therapy with monthly IV infusions at a local med spa. He noticed some immediate effects for a few days after each session but felt the benefit faded before his next appointment. He switched to a twice-weekly at-home injection protocol prescribed by a telehealth provider. After six weeks, his energy and cognitive performance were noticeably more consistent — not because the per-session dose was higher, but because the cumulative effect of consistent twice-weekly dosing was greater than the spaced peaks from monthly IVs.
When IV Might Be Preferred
There are situations where IV infusions make sense:
Initial loading protocol: Some providers use a series of IV infusions at the start of a NAD+ protocol to rapidly elevate depleted levels, then transition to at-home injections for maintenance. This approach combines IV's high-peak advantage with injection's sustainability.
Severe depletion or acute clinical need: For people with significant NAD+ depletion from illness, certain medications, or intensive detoxification protocols, the high-concentration delivery of IV may be clinically preferable in the initial phase.
Preference and access: Some people prefer the clinic environment, the assurance of professional administration, and the passive experience of IV infusion over self-injection. This is a valid preference, particularly for those with needle anxiety about self-administration.
Combined IV cocktails: IV therapy often combines NAD+ with other compounds (glutathione, vitamin C, B vitamins) in a single infusion. If you're seeking combination therapy, an IV clinic may provide more flexibility.
Cost-Effectiveness Over 12 Months
Let's look at what sustained protocols actually cost:
IV infusion, 2x/week average: ~$400/week → ~$20,800/year At-home injection, 3x/week: ~$100-$150/week → ~$5,200-$7,800/year
The financial difference funds roughly 3-4 additional years of at-home injection therapy. For most people, that long-term consistency produces superior outcomes to twice the cost of intermittent high-dose sessions.
What About Oral NAD+ Precursors (NMN, NR)?
For completeness: oral NAD+ precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are significantly less effective than either IV or injectable NAD+ for therapeutic goals.
They do modestly raise NAD+ levels in some people, which is why they're useful for maintenance in people who aren't significantly depleted. But for people with meaningful depletion or specific therapeutic goals, the plasma levels achieved by oral precursors are not comparable to injectable forms.
Injectable NAD+ delivers the active compound directly. No conversion required. No absorption efficiency limitations. The difference in plasma concentration is not a minor distinction.
Getting Started with NAD+ Injections
A provider-guided at-home injection protocol involves:
- Online health intake. A licensed provider reviews your health history and goals.
- Personalized prescription. Your provider recommends dose, concentration, and frequency tailored to your situation.
- Shipped to your door. Medication, supplies, and administration instructions delivered directly.
- Ongoing provider access. Secure messaging for questions about administration or your response to treatment.
Explore NAD+ injection protocols at Livv Telehealth and see if you qualify.
For a full breakdown of NAD+'s benefits and mechanisms, see our guide: NAD+ Injection Benefits: What the Research Actually Shows
Key Takeaways
- Both IV infusions and injections bypass digestion and achieve significantly higher plasma NAD+ than oral supplements
- IV achieves higher peak concentrations per session. Injections achieve high and therapeutically sufficient levels.
- For sustained protocols, injections win on cost (3-5x less expensive), convenience (self-administered in 2 minutes at home), and real-world compliance
- IV may be preferred for initial high-dose loading, severe depletion, or if you prefer clinical administration
- Consistency is the most important variable for NAD+ outcomes. A 3x/week at-home protocol consistently outperforms a once-monthly IV in cumulative effect
- Starting cost at home: typically $50-$150 per session vs. $200-$600 per clinic IV
If you're ready to start a sustainable, provider-guided NAD+ protocol, see if you qualify for at-home injections at Livv Telehealth.
This article is for informational purposes only and does not constitute medical advice. Consult a licensed provider before starting any new supplement or treatment protocol.
